Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the Digital LightCyclerⓇ System, Roche's first digital polymerase chain reaction ( PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. 
A condition linked to thousands of UK deaths has been significantly reduced by healthcare professionals at County Durham and Darlington NHS Foundation Trust, with the help of a new care model, supported by specialist nurses, and developed in partnership with NHS technology provider C2-Ai.
Created to help identify and promptly treat patients in hospital at risk from acute kidney injury, the project has led to a reduction in hospital acquired AKI of more than 80%.
Two of the NHS' most dynamic chief information officers have joined Highland Marketing’s advisory board of NHS IT professionals and health tech industry experts.
Ian Hogan, a CIO at the Northern Care Alliance NHS Foundation Trust and Neil Perry, the director of digital transformation at Dartford and Gravesham NHS Trust, have joined the expert group that acts as a discussion forum for issues relating to digital health and provides advice to the agency and its clients.
Digital health company Health Fabric is preparing to work with Sandwell Council after learning that it has secured support from The Healthy Ageing Challenge.
The company will work with public health experts and local communities on Healthy Sandwell programmes, following the successful bid to the "game changing" fund run by UK Research and Innovation and Innovate UK.
The Northern Care Alliance NHS Foundation Trust, one of the largest NHS organisations in the country based in Greater Manchester, is working with CliniSys to deploy a single, laboratory information system across its pathology services to improve clinical practice and patient care. 
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors. The programme has been commissioned on behalf of the South and North London Cardiac Operational Delivery Networks, with £750,000 of transformation funding from NHSX (now part of the NHS England transformation directorate).